Approximately 10-20% of sporadic hemiplegic migraine patients may carry one of these mutations, particularly ATP1A2. However, routine genetic testing is not required for diagnosis and is reserved for atypical or severe cases. Here, ATP1A2 is linked to migraine disorder.